Autres langues Hester Biosciences Limited

Actions

HESTERBIO

INE782E01017

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:54 17/06/2026			Varia. 5j.	Varia. 1 janv.
2 054,10 ^INR	+0,37%		+6,18%	+29,03%

15/05	Transcript : Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026
15/05	Le bénéfice consolidé de Hester Biosciences s'envole au T4 ; le titre bondit de 10%	MT

Autres langues

15/05	Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10%
15/05	Hester Biosciences Limited Recommends Dividend for the Financial Year 2025-26
15/05	Hester Biosciences March-quarter consol net profit 159.8 million rupees
15/05	Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
12/05	Hester Biosciences Limited Announces Board Changes, Effective May 12, 2026
11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences
11/03	Ticop Life Private Limited entered into an agreement to acquire an additional 43.81% stake in Texas Laboratories from Hester Biosciences Limited for INR 92 million.
30/01	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
30/01	Hester Biosciences re-appoints Rajiv Gandhi as CEO & MD
24/01	Hester Biosciences Limited Receives the Manufacturing License from the Food & Drugs Control Administration
20/11	Hester Biosciences says Ashish Desai appointed as chief financial officer
20/11	Hester Biosciences Appoints CFO
20/11	Hester Biosciences Limited Appoints Ashish Desai as Key Managerial Personnel, with Effect from 20 November 2025
20/11	Hester Biosciences Limited Appoints Ashish Desai as Chief Financial Officer, with Effect from 20 November 2025
14/11	Hester Biosciences CFO Resigns
12/11	Indian Equities Extend Winning Run on NDA Exit Poll Boost, Global Optimism
12/11	Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
12/11	Hester Biosciences' Consolidated Profit Declines in Fiscal Q2; Shares Down 3%
01/08/25	Hester Biosciences Consolidated Net Profit Jumps in Fiscal Q1; Shares Jump 12%
01/08/25	Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
09/05/25	Hester Biosciences Limited Proposes Dividend for the Financial Year Ended 31 March 2025, Payable on or After19 August 2025
09/05/25	Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025
14/02/25	Hester Biosciences Limited Approves Shifting of Registered Office
30/01/25	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024